Key result
High sensitivity troponin T was significantly associated with mixed coronary plaque morphology in patients with suspected CAD (OR 8.968; 95% CI 1.999-40.241; p=0.004).
Why the study?
Do high sensitivity troponin levels correlate with specific coronary artery plaque morphologies on CCTA in patients with suspected CAD?
Observational (n=99)
Do high sensitivity troponin levels correlate with specific coronary artery plaque morphologies on CCTA in patients with suspected CAD?
Effect estimate: OR 8.968 (95% CI 1.999-40.241)
p-value: p=0.004
High-sensitivity troponin T levels are significantly associated with the presence of mixed coronary plaques on CCTA in patients with suspected CAD.
hsTnT association with mixed plaques is hypothesis-generating; prospective studies needed before clinical adoption in suspected CAD.
Background. This study evaluates the association between high sensitivity troponin I (hsTnI) and T (hsTnT) and the morphology of coronary artery plaques detected by coronary computed tomography angiography (CCTA) in patients with suspected coronary artery disease (CAD). Methods. Patients undergoing CCTA were prospectively enrolled. CCTA was indicated by a low to intermediate pretest probability for CAD during routine clinical care. Within 24 hours of CCTA examination, peripheral blood samples were taken to measure hsTnI, hsTnT, and N-terminal probrain natriuretic peptide (NT-proBNP). Results. A total of 99 patients were enrolled with 43% without CAD, 9% with noncalcified plaques, 28% with calcified plaques, and 19% with mixed type plaque lesions. Both hsTnI and hsTnT levels were able to discriminate significantly between the groups, especially in the presence of mixed coronary plaques (AUC range: 0.741–0.752; p=0.0001). In multivariate logistic regression models, hsTnT, but not hsTnI, was still significantly associated with mixed coronary plaque morphology (odds ratio = 8.968; 95% CI 1.999–40.241; p=0.004). Conclusions. Both hsTnI and hsTnT are able to discriminate between different coronary artery plaques morphologies, whereas hsTnT was significantly associated with mixed coronary plaques in patients with suspected CAD. This trial is registered with NCT03074253 .
No takes yet. Share an insight, caveat, or question.
Rusnak et al. (2017) conducted an observational in suspected coronary artery disease (CAD) (n=99). High sensitivity troponin I (hsTnI) and T (hsTnT) was evaluated on Association with mixed coronary plaque morphology (OR 8.968, 95% CI 1.999-40.241, p=0.004). High sensitivity troponin T was significantly associated with mixed coronary plaque morphology in patients with suspected CAD (OR 8.968; 95% CI 1.999-40.241; p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: